Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114915) titled 'Observational study of sustained-release hydromorphone tablets for refractory cancer pain in China' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The second affiliated hospital of Zhejiang University school of medicine
Condition:
Chronic cancer pain
Intervention:
Hydromorphone Extended Release Tablets Group:Hydromorphone Extended Release Tablets
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-31
Target Sample Size: Hydromorphone Extended Release Tablets Group:50;Oxycodone Extended Release Tablets Group:50;
Countries of Re...